订阅小程序
旧版功能

FIRST-IN-HUMAN PHASE 1/2 STUDY OF THE FIRST-IN-CLASS SUMO-ACTIVATING ENZYME INHIBITOR TAK-981 IN PATIENTS WITH ADVANCED OR METASTATIC SOLID TUMORS OR RELAPSED/REFRACTORY LYMPHOMA: PHASE 1 RESULTS

Arkadiusz Dudek,Dejan Juric,Afshin Dowlati,Ulka Vaishampayan,Hadeel Assad,Jordi Rodon,Bo Chao,Bingxia Wang,John Gibbs,Vaishali Shinde,Sharon Friedlander,Allison Berger,Christine Ward,Alonzo Martinez,Robert Gharavi,Alejandro Gomez-Pinillos,Igor Proscurshim,Anthony Olszanski

JOURNAL FOR IMMUNOTHERAPY OF CANCER（2021）

引用 2|浏览9
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要